Compound ID | 2292
Class: Lipopeptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to both C55-P and C55-PP |
| Target Pathogen: | Active against Staphylococcus aureus and Enterococcus faecium, vancomycin-resistant Enterococcus, and Clostridioides difficile |
| Description: | Natural product from Paenibacillus mucilaginosus strains; predicted structure was chemically synthesized based on biosynthetic gene cluster(syn-BNP) |
| Year first mentioned: | 2022 |
| Development status: | Experimental |
| External links: | |
| Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/171038003 |
| Citation: | https://www.science.org/doi/10.1126/science.abn4213 |